药学研究
藥學研究
약학연구
JOURNAL OF PHARMACEUTICAL RESEARCH
2014年
11期
626-627,630
,共3页
杨斌%杨小叶%曾春%刘元%曹斌
楊斌%楊小葉%曾春%劉元%曹斌
양빈%양소협%증춘%류원%조빈
左旋-二脱水伊地醇双甲磺酸酯%HL-60细胞%含药血清
左鏇-二脫水伊地醇雙甲磺痠酯%HL-60細胞%含藥血清
좌선-이탈수이지순쌍갑광산지%HL-60세포%함약혈청
DMDAI-L%HL-60 cells%Medicated serum
目的:探讨左旋-二脱水伊地醇双甲磺酸酯含药血清对 HL-60细胞的增殖抑制作用。方法运用CCK-8法测定不同剂量组DMDAI-L的含药血清对HL-60细胞的增殖影响。结果 DMDAI-L高中低剂量组含药血清作用 HL -60细胞48 h 抑制率分别为30.29%、20.72%、13.97%,而阳性组(环磷酰胺)抑制率为18.16%,高、中、低剂量组、阳性对照组与空白对照组比较有显著性差异( P<0.05)。结论 DMDAI-L含药血清能够有效抑制HL-60细胞增殖。
目的:探討左鏇-二脫水伊地醇雙甲磺痠酯含藥血清對 HL-60細胞的增殖抑製作用。方法運用CCK-8法測定不同劑量組DMDAI-L的含藥血清對HL-60細胞的增殖影響。結果 DMDAI-L高中低劑量組含藥血清作用 HL -60細胞48 h 抑製率分彆為30.29%、20.72%、13.97%,而暘性組(環燐酰胺)抑製率為18.16%,高、中、低劑量組、暘性對照組與空白對照組比較有顯著性差異( P<0.05)。結論 DMDAI-L含藥血清能夠有效抑製HL-60細胞增殖。
목적:탐토좌선-이탈수이지순쌍갑광산지함약혈청대 HL-60세포적증식억제작용。방법운용CCK-8법측정불동제량조DMDAI-L적함약혈청대HL-60세포적증식영향。결과 DMDAI-L고중저제량조함약혈청작용 HL -60세포48 h 억제솔분별위30.29%、20.72%、13.97%,이양성조(배린선알)억제솔위18.16%,고、중、저제량조、양성대조조여공백대조조비교유현저성차이( P<0.05)。결론 DMDAI-L함약혈청능구유효억제HL-60세포증식。
Objective To detect the effect of serum containing DMDAI-L on human myeloid leukemia HL-60 cells. MetHods The proliferation inhibitory effect of serum containing DMDAI-L on human myeloid leukemia HL-60 cells were detected by CCK-8 assay in vitro. Results The high,medium and low-dose groups of serum containing DMDAI-L can inhibit the growth of HL -60 cells,the inhibition rate of high,medium and low -dose groups for 48 hours were 30. 29%,20. 72%,13. 97%and cyclophosphamide group was 18. 16%,there was significantly difference related to the con-trol group(P<0. 05). CoNclusioN The serum containing DMDAI-L can inhibit the growth of HL-60 cells effectively.